Let-7a inhibits growth and migration of breast cancer cells by targeting HMGA1

Kui Liu1, Chunfu Zhang2, Tao Li1

  • 1School of Medicine, Jiangsu University, Jiangsu Key Laboratory of Clinical Laboratory Medicine, Zhenjiang, Jiangsu 212013, P.R. China.

Insights

Let-7a, a microRNA, acts as a tumor suppressor in breast cancer by inhibiting cell growth and spread. Its reduced expression in tumors suggests a potential therapeutic target for breast cancer treatment.

Area of Science:

  • Molecular Biology
  • Oncology
  • Gene Regulation

Background:

  • Let-7 microRNAs (miRNAs) are known regulators of breast cancer cell self-renewal and tumorigenicity.
  • The specific role of let-7a in breast cancer progression remains incompletely understood.
  • Understanding let-7a's function is crucial for developing novel breast cancer therapies.

Purpose of the Study:

  • To investigate the expression levels of let-7a in breast cancer.
  • To elucidate the functional impact of let-7a on breast cancer cell behavior.
  • To identify target genes regulated by let-7a in breast cancer.

Main Methods:

  • Quantitative real-time PCR (qRT-PCR) to measure let-7a expression in cancer cells and tissues.
  • In vitro cell culture assays to assess proliferation, colony formation, migration, and invasion.
  • Western blotting to analyze the expression of potential target genes, specifically High Mobility Group A1 (HMGA1).

Main Results:

  • Let-7a expression was significantly downregulated in breast cancer cells and tissues compared to normal controls.
  • Overexpression of let-7a suppressed breast cancer cell proliferation, colony formation, migration, and invasion.
  • HMGA1 was identified as a direct target of let-7a, with its protein expression inversely correlated to let-7a levels.

Conclusions:

  • Let-7a functions as a tumor suppressor in breast cancer.
  • The tumor-suppressive role of let-7a is mediated, at least in part, by targeting HMGA1.
  • Targeting let-7a or its downstream effectors may offer new therapeutic strategies for breast cancer.

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.5K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K
Hedgehog Signaling Pathway02:33

Hedgehog Signaling Pathway

The Hedgehog gene (Hh) was first discovered due to its control of the growth of disorganized, hair-like bristles phenotype in Drosophila, much like hedgehog spines. Hh plays a crucial role in the development of organs and the maintenance of homeostasis in both invertebrates and vertebrates. However, while Drosophila has only one Hh protein, mammals have multiple functional Hedgehog proteins - Sonic (Shh), Desert (Dhh), and Indian Hedgehog (Ihh). All of these homologous proteins have adapted to...
10.4K